161 related articles for article (PubMed ID: 18378535)
21. Surfactant-polymer nanoparticles enhance the effectiveness of anticancer photodynamic therapy.
Khdair A; Gerard B; Handa H; Mao G; Shekhar MP; Panyam J
Mol Pharm; 2008; 5(5):795-807. PubMed ID: 18646775
[TBL] [Abstract][Full Text] [Related]
22. Liposomal nanomedicines as anticancer therapeutics: beyond targeting tumor cells.
Schiffelers RM; Storm G
Int J Pharm; 2008 Dec; 364(2):258-64. PubMed ID: 18773947
[TBL] [Abstract][Full Text] [Related]
23. High cytotoxicity of cisplatin nanocapsules in ovarian carcinoma cells depends on uptake by caveolae-mediated endocytosis.
Hamelers IH; Staffhorst RW; Voortman J; de Kruijff B; Reedijk J; van Bergen en Henegouwen PM; de Kroon AI
Clin Cancer Res; 2009 Feb; 15(4):1259-68. PubMed ID: 19228729
[TBL] [Abstract][Full Text] [Related]
24. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
[TBL] [Abstract][Full Text] [Related]
25. Methods and Study Designs for Characterizing the Pharmacokinetics and Pharmacodynamics of Carrier-Mediated Agents.
Schorzman AN; Lucas AT; Kagel JR; Zamboni WC
Methods Mol Biol; 2018; 1831():201-228. PubMed ID: 30051434
[TBL] [Abstract][Full Text] [Related]
26. A new drug-delivery-system of anticancer agents: activated carbon particles adsorbing anticancer agents.
Hagiwara A; Takahashi T
In Vivo; 1987; 1(4):241-52. PubMed ID: 2979791
[TBL] [Abstract][Full Text] [Related]
27. Complex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents.
Lucas AT; Price LS; Schorzman A; Zamboni WC
Nanomedicine (Lond); 2017 Aug; 12(16):2021-2042. PubMed ID: 28745129
[TBL] [Abstract][Full Text] [Related]
28. Ligand based dendritic systems for tumor targeting.
Agarwal A; Saraf S; Asthana A; Gupta U; Gajbhiye V; Jain NK
Int J Pharm; 2008 Feb; 350(1-2):3-13. PubMed ID: 18162345
[TBL] [Abstract][Full Text] [Related]
29. pH-responsive nanoparticles for cancer drug delivery.
Shen Y; Tang H; Radosz M; Van Kirk E; Murdoch WJ
Methods Mol Biol; 2008; 437():183-216. PubMed ID: 18369970
[TBL] [Abstract][Full Text] [Related]
30. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect.
Maeda H; Bharate GY; Daruwalla J
Eur J Pharm Biopharm; 2009 Mar; 71(3):409-19. PubMed ID: 19070661
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of fixed dosing of new anticancer agents in phase I studies.
Levêque D
Anticancer Res; 2008; 28(5B):3075-7. PubMed ID: 19031959
[TBL] [Abstract][Full Text] [Related]
32. Folate and folate-PEG-PAMAM dendrimers: synthesis, characterization, and targeted anticancer drug delivery potential in tumor bearing mice.
Singh P; Gupta U; Asthana A; Jain NK
Bioconjug Chem; 2008 Nov; 19(11):2239-52. PubMed ID: 18950215
[TBL] [Abstract][Full Text] [Related]
33. The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation.
Tseng CL; Su WY; Yen KC; Yang KC; Lin FH
Biomaterials; 2009 Jul; 30(20):3476-85. PubMed ID: 19345990
[TBL] [Abstract][Full Text] [Related]
34. Thermosensitive polymer-conjugated albumin nanospheres as thermal targeting anti-cancer drug carrier.
Shen Z; Wei W; Zhao Y; Ma G; Dobashi T; Maki Y; Su Z; Wan J
Eur J Pharm Sci; 2008 Nov; 35(4):271-82. PubMed ID: 18721874
[TBL] [Abstract][Full Text] [Related]
35. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee A; Vishwanatha JK
Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
[TBL] [Abstract][Full Text] [Related]
36. Controlled application and scheduled removal of nanoparticle based chemotherapeutics (CARL) will reduce dose limiting adverse events in anticancer chemotherapy.
Pütz G; Schmah O; Eckes J; Hug MJ; Winkler K
Med Hypotheses; 2009 Apr; 72(4):393-7. PubMed ID: 19147297
[TBL] [Abstract][Full Text] [Related]
37. Design and evaluation of itraconazole loaded solid lipid nanoparticulate system for improving the antifungal therapy.
Mukherjee S; Ray S; Thakur RS
Pak J Pharm Sci; 2009 Apr; 22(2):131-8. PubMed ID: 19339221
[TBL] [Abstract][Full Text] [Related]
38. Liposomal, nanoparticle, and conjugated formulations of anticancer agents.
Zamboni WC
Clin Cancer Res; 2005 Dec; 11(23):8230-4. PubMed ID: 16322279
[No Abstract] [Full Text] [Related]
39. Active targeting schemes for nanoparticle systems in cancer therapeutics.
Byrne JD; Betancourt T; Brannon-Peppas L
Adv Drug Deliv Rev; 2008 Dec; 60(15):1615-26. PubMed ID: 18840489
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic and diagnostic applications of dendrimers for cancer treatment.
Wolinsky JB; Grinstaff MW
Adv Drug Deliv Rev; 2008 Jun; 60(9):1037-55. PubMed ID: 18448187
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
